Part D Muddies Script Counts

Prescription tracking data from companies like IMS Health have shown a disproportionate increase in volume since the start of the Part D benefit in January, according to an analysis by Prudential Securities analyst Tim Anderson. One reason is in the way the Medicare drug benefit appears to increase the number of new prescriptions for brands.